back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 12:10 Tx date 2024-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-45,250 vol |
137,750 | |
| Filed 2026-06-09 12:09 Tx date 2025-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-48,000 vol |
228,500 | |
| Filed 2026-06-09 12:05 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-228,500 vol |
0 | |
| Filed 2026-06-09 11:54 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-423,000 vol |
0 | |
| Filed 2026-06-08 21:47 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-268,800.80
-336,001 vol $0.80 each |
0 | |
| Filed 2024-12-28 23:06 Tx date 2024-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,436
+86,000 vol $0.60 each |
336,001 | |
| Filed 2024-12-28 22:53 Tx date 2024-12-23 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$76,312
+138,750 vol $0.55 each |
321,750 | |
| Filed 2024-01-02 22:38 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$41,400
+90,000 vol $0.46 each |
183,000 | |
| Filed 2024-01-02 22:32 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,730
+25,500 vol $0.46 each |
423,000 | |
| Filed 2023-12-29 09:15 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,112
+33,443 vol $0.4818 each |
250,001 | |
| Filed 2023-12-29 09:07 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,752
+25,500 vol $0.4609 each |
216,558 | |
| Filed 2023-12-29 09:06 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,540
+20,000 vol $0.477 each |
191,058 | |
| Filed 2023-12-29 09:05 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,100
+30,000 vol $0.47 each |
171,058 | |
| Filed 2023-12-27 09:07 Tx date 2023-12-22 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,405
+33,500 vol $0.43 each |
141,058 | |
| Filed 2023-12-27 09:05 Tx date 2023-12-20 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+1,000 vol $0.40 each |
107,558 | |
| Filed 2023-09-05 12:55 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,335
+24,750 vol $0.66 each |
397,500 | |
| Filed 2023-06-25 22:59 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,087
+24,750 vol $0.65 each |
372,750 | |
| Filed 2022-01-05 11:55 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+48,000 vol |
93,000 | |
| Filed 2022-01-05 11:18 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
348,000 | |
| Filed 2021-12-16 21:46 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,170
+3,500 vol $0.62 each |
106,558 |